Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ·Healthcare·Biotechnology
$29.56
+2.92%
Mkt Cap $1.72B
Analyst Ratings
Buy
10
Hold
3
Sell
0
Price Target (21 analysts)
$37.75
Range $25.00 – $50.00
Implied Upside
+27.7%
Consensus $37.75 vs current $29.56
NASDAQ·Healthcare·Biotechnology
$29.56
+2.92%
Mkt Cap $1.72B
Buy
10
Hold
3
Sell
0
Price Target (21 analysts)
$37.75
Range $25.00 – $50.00
+27.7%
Consensus $37.75 vs current $29.56